COVID-19 Vaccine: Serum Institute of India Restarts Manufacturing Covishield Vaccines, CEO Adar Poonawalla Confirms ‘6–7 Million Doses’ To Be Available in 90 Days
Serum Institute of India (SII) has restarted the manufacturing of Covishield Vaccines, amid the rising number of COVID-19 cases in the country. CEO Adar Poonawalla has confirmed ‘6–7 Million doses’ to be made available in 90 days.
- Read in
- తెలుగు
Amid the rising number of Covid-19 cases across the country, Serum Institute of India (SII) is going to restart the manufacturing of Covishield vaccines. The CEO OF SII, Adar Poonawalla, announced that "6-7 million doses available in 90 days". COVID-19 Surge in India: Coronavirus Moving Towards Endemic Stage, Cases May Rise for Next 10-12 Days.
Covidshield Vaccine Production Steadfast
Serum Institute of India restarts manufacturing Covishield vaccines, will make 6-7 million doses available in 90 days: CEO Adar Poonawalla
— Press Trust of India (@PTI_News) April 12, 2023
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Apr 12, 2023 05:21 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
